Erythrocyte Transfusion

Subscribe to Selected New Research on Erythrocyte Transfusion

481 relevant articles (23 outcomes, 42 trials/studies) found for this Therapy

Description: The transfer of erythrocytes from a donor to a recipient or reinfusion to the donor.

Also Known As:

Red Blood Cell Transfusions; Transfusion, Red Blood Cell; Transfusions, Red Blood Cell; Erythrocyte Transfusions; Transfusion, Erythrocyte; Transfusions, Erythrocyte; Red Blood Cell Transfusion

Relationship Network

Therapy Context: Research Results

Therapeutics: 5195

Biological Therapy: 773

Blood Transfusion: 8375

Blood Component Transfusion: 28

Erythrocyte Transfusion: 481

Experts

1.	Corwin, Howard L: 3 articles (09/2008 - 04/2004)
2.	De Backer, Daniel: 2 articles (07/2007 - 04/2003)
3.	Vincent, Jean-Louis: 2 articles (07/2007 - 04/2003)
4.	Shorr, Andrew F: 2 articles (01/2007 - 03/2004)
5.	Quainon, Fabienne: 2 articles (10/2006 - 12/2005)
6.	O'Brien, Jacklyn: 2 articles (09/2006 - 10/2002)
7.	Veremakis, Christopher: 2 articles (09/2006 - 10/2002)
8.	Taylor, Robert W: 2 articles (09/2006 - 10/2002)
9.	Manganaro, Lisa: 2 articles (09/2006 - 10/2002)
10.	Trottier, Steven J: 2 articles (09/2006 - 10/2002)

Related Diseases

1.	Anemia 11/01/2007 - "The development of the erythropoiesis-stimulating agent epoetin represented a major step forward in the treatment of chemotherapy-related anemia, providing an effective and safe alternative to red blood cell transfusions" 01/01/2005 - "Randomized controlled trials comparing prophylaxis or treatment of anemia with EPO plus red blood cell transfusion (RBCT) or RBCT only in patients with malignant disease undergoing antineoplastic therapy were included" 04/01/2001 - "The Viral Activation Transfusion Study (VATS) was a randomized trial that compared leukocyte-reduced transfusions with unfiltered red blood cell transfusions in HIV and cytomegalovirus (CMV) antibody-positive patients with anemia who were undergoing their first blood transfusion" 09/01/2008 - "Effects on anemia could not be investigated as several patients received erythrocyte transfusion" 04/01/2008 - "SUMMARY: Both severe anemia and red blood-cell transfusion may negatively influence clinical outcome in neurocritical patients" Get all the results and reference details, order at left...
2.	Neoplasms (Cancer) 01/01/2006 - "Until recently, red blood cell transfusions were the mainstay of treatment for cancer-related anaemia" 09/01/2008 - "However, although recombinant human Epo (rHuEPO) significantly reduces the risk for red blood cell transfusions in cancer patients, recent clinical studies have reported decreased survival and disease control following rHuEPO treatment in patients with different cancer types" 09/01/2008 - "Intraoperative allogeneic red blood cell transfusion in ampullary cancer outcome after curative pancreatoduodenectomy: a clinical study and meta-analysis." 09/01/2007 - "Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study." 01/01/2006 - "SELECTION CRITERIA: Randomised controlled trials on managing anaemia in cancer patients that compared the use of Epo/Darbepo (plus transfusion if needed) with observation until red blood cell transfusion was required" Get all the results and reference details, order at left...
3.	Critical Illness (Critically Ill) 09/01/2008 - "Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature." 04/01/2004 - "Efficacy of red blood cell transfusion in the critically ill." 01/01/2008 - "Although studies have suggested that the adoption of a more restrictive transfusion strategy may be safely applied to critically ill adult and all-cause critically ill pediatric patients, recent developments in our understanding of the negative consequences of red blood cell transfusion have focused almost entirely on adult populations, while the applicability of these findings to the pediatric population remains poorly defined" 01/01/2008 - "Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients." 08/01/2007 - "Red blood cell transfusion in critically ill children is independently associated with increased mortality." Get all the results and reference details, order at left...
4.	Iron Overload 07/01/2008 - "Allogeneic hematopoietic cell transplant (HCT) recipients frequently need red blood cell transfusions, and can be at risk for developing iron overload" 02/01/2008 - "Red blood cell transfusions are a therapeutic mainstay in SCD and repeated transfusions can result in iron overload" 12/01/2004 - "Chronic red blood cell transfusions expose patients to various side-effects, including blood components intolerance reactions and alloimmunization risks, but also increased frequency of iron overload, a more significant problem in low-risk heavily transfused MDS patients, who have prolonged life expectancy" 07/01/2000 - "Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy." 01/01/1981 - "Iron overload, predominantly found during haemodialysis, depended on the number of erythrocyte transfusions given and was found to be more pronounced in patients with HLA A3 and/or B7" Get all the results and reference details, order at left...
5.	Sepsis (Septicemia) 07/01/2007 - "Monitoring efficacy of red blood cell transfusion in sepsis by sublingual microvascular perfusion: a tongue speaks without words." 07/01/2008 - "Streptococcus pneumoniae septicemia associated with red blood cell transfusion." 10/01/2007 - "Does red blood cell transfusion result in a variate microvascular response in sepsis?" 07/01/2007 - "PATIENTS: Thirty-five patients with severe sepsis requiring red blood cell transfusions" 07/01/2007 - "We investigated the effects of red blood cell transfusion on sublingual microvascular perfusion in patients with sepsis" Get all the results and reference details, order at left...
190 Diseases and 481 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Erythropoietin
2.	Hemoglobins (Hemoglobin)
3.	Epoetin Alfa (Epogen)
4.	Oxygen
5.	Proteins (Proteins, Gene)
6.	A 19
7.	Granulocyte Colony-Stimulating Factor (G-CSF)
8.	Anti-Bacterial Agents (Antibiotics)
9.	recombinant FVIIa (rFVIIa)
10.	Lactoferrin
106 Drugs and Important Bio-Agents and 169 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Platelet Transfusion (Blood Platelet Transfusions)
3.	Chest Tubes (Chest Tube)
4.	Therapeutics
5.	Blood Transfusion (Blood Transfusions)
42 Therapies and Procedures and 93 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>